Pharmacotherapeutic evaluation of Paribhadra Patra (Erythrina variegata Linn.) and Amlaki phala (Emblica officinalis Gaertn.) in the management of Amlapitta (Hyperacidity) - An exploratory study
Trial Snapshot
- Phase
- Phase 3 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Changes in the objective parameters
Study Overview
Brief Summary
My study titled "Pharmacotherapeutical Evaluation of Paribhadra Patra and Amalaki Phala in the Management of Amlapitta (Hyperacidity)" focuses on assessing the effectiveness of two traditional Ayurvedic remedies—Paribhadra Patra (leaves of Erythrina variegata) and Amalaki Phala (fruit of the Indian gooseberry)—in treating Amlapitta, commonly known as hyperacidity.
The research evaluates the pharmacological properties, therapeutic actions, and potential benefits of these remedies in alleviating symptoms such as indigestion, acidity, and gastritis. The study aims to provide scientific evidence supporting their use in managing hyperacidity and offers insights into their mechanisms of action, dosage, and safety profile in the context of Ayurvedic treatment practices.
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Open Label
Eligibility Criteria
- Ages
- 16.00 Year(s) to 50.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Clinically and pathologically diagnosed patient , who are suffering from Amlapitta.
Exclusion Criteria
- •Subject should not suffering from Amlapitta more than 3 months
- •Age below 16 years and above 50 years
- •Subject reporting with complication like cardiac problem , emphysema, carcinoma etc.
- •will be excluded
- •Pregnant woman and lactating mothers was excluded
- •Subject with gastric malignancy
- •Subject who recently undergo gastro-intestinal surgery.
Outcomes
Primary Outcomes
Changes in the objective parameters
Time Frame: 1 month
Secondary Outcomes
- Changes in the clinical sign and symptoms of Amlapitta(1 month)